nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—ORM1—bile—stomach cancer	0.0441	0.238	CbGeAlD
Disopyramide—CHRM3—muscle of abdomen—stomach cancer	0.0404	0.218	CbGeAlD
Disopyramide—ORM1—gall bladder—stomach cancer	0.0122	0.0661	CbGeAlD
Disopyramide—KCND3—pancreas—stomach cancer	0.0103	0.0556	CbGeAlD
Disopyramide—ORM1—hematopoietic system—stomach cancer	0.00692	0.0374	CbGeAlD
Disopyramide—KCND3—liver—stomach cancer	0.00654	0.0354	CbGeAlD
Disopyramide—SLC22A2—digestive system—stomach cancer	0.00624	0.0337	CbGeAlD
Disopyramide—SCN5A—digestive system—stomach cancer	0.00527	0.0285	CbGeAlD
Disopyramide—KCND3—lymph node—stomach cancer	0.00502	0.0271	CbGeAlD
Disopyramide—CHRM3—smooth muscle tissue—stomach cancer	0.00463	0.025	CbGeAlD
Disopyramide—ORM1—bone marrow—stomach cancer	0.00444	0.024	CbGeAlD
Disopyramide—ORM1—endocrine gland—stomach cancer	0.00398	0.0215	CbGeAlD
Disopyramide—CHRM2—endocrine gland—stomach cancer	0.00371	0.02	CbGeAlD
Disopyramide—CHRM3—digestive system—stomach cancer	0.00366	0.0198	CbGeAlD
Disopyramide—SLC22A1—endocrine gland—stomach cancer	0.00364	0.0197	CbGeAlD
Disopyramide—ORM1—liver—stomach cancer	0.00359	0.0194	CbGeAlD
Disopyramide—CHRM1—endocrine gland—stomach cancer	0.00338	0.0182	CbGeAlD
Disopyramide—SLC22A1—liver—stomach cancer	0.00328	0.0177	CbGeAlD
Disopyramide—CHRM3—endocrine gland—stomach cancer	0.00302	0.0163	CbGeAlD
Disopyramide—CYP3A4—hematopoietic system—stomach cancer	0.00289	0.0156	CbGeAlD
Disopyramide—ORM1—lymph node—stomach cancer	0.00275	0.0149	CbGeAlD
Disopyramide—CYP3A4—digestive system—stomach cancer	0.00201	0.0109	CbGeAlD
Disopyramide—CYP3A4—endocrine gland—stomach cancer	0.00166	0.00897	CbGeAlD
Disopyramide—CYP3A4—liver—stomach cancer	0.0015	0.00809	CbGeAlD
Disopyramide—Dyspnoea—Fluorouracil—stomach cancer	0.00125	0.00202	CcSEcCtD
Disopyramide—Somnolence—Fluorouracil—stomach cancer	0.00124	0.00201	CcSEcCtD
Disopyramide—Dyspepsia—Fluorouracil—stomach cancer	0.00123	0.00199	CcSEcCtD
Disopyramide—Arrhythmia—Capecitabine—stomach cancer	0.00123	0.00199	CcSEcCtD
Disopyramide—Muscular weakness—Epirubicin—stomach cancer	0.00122	0.00198	CcSEcCtD
Disopyramide—Cardiac arrest—Doxorubicin—stomach cancer	0.00122	0.00197	CcSEcCtD
Disopyramide—Decreased appetite—Fluorouracil—stomach cancer	0.00121	0.00197	CcSEcCtD
Disopyramide—Dysgeusia—Docetaxel—stomach cancer	0.00121	0.00196	CcSEcCtD
Disopyramide—Abdominal distension—Epirubicin—stomach cancer	0.0012	0.00195	CcSEcCtD
Disopyramide—Feeling abnormal—Irinotecan—stomach cancer	0.0012	0.00195	CcSEcCtD
Disopyramide—Blood creatinine increased—Doxorubicin—stomach cancer	0.0012	0.00194	CcSEcCtD
Disopyramide—Dysuria—Methotrexate—stomach cancer	0.0012	0.00194	CcSEcCtD
Disopyramide—Neutropenia—Methotrexate—stomach cancer	0.0012	0.00194	CcSEcCtD
Disopyramide—Pain—Fluorouracil—stomach cancer	0.00119	0.00194	CcSEcCtD
Disopyramide—Flatulence—Capecitabine—stomach cancer	0.00118	0.00191	CcSEcCtD
Disopyramide—Erectile dysfunction—Methotrexate—stomach cancer	0.00118	0.00191	CcSEcCtD
Disopyramide—Dysgeusia—Capecitabine—stomach cancer	0.00117	0.0019	CcSEcCtD
Disopyramide—Abdominal pain upper—Doxorubicin—stomach cancer	0.00117	0.0019	CcSEcCtD
Disopyramide—Hypokalaemia—Doxorubicin—stomach cancer	0.00117	0.00189	CcSEcCtD
Disopyramide—Body temperature increased—Irinotecan—stomach cancer	0.00115	0.00187	CcSEcCtD
Disopyramide—Feeling abnormal—Fluorouracil—stomach cancer	0.00115	0.00187	CcSEcCtD
Disopyramide—Drowsiness—Methotrexate—stomach cancer	0.00114	0.00185	CcSEcCtD
Disopyramide—Depression—Methotrexate—stomach cancer	0.00114	0.00184	CcSEcCtD
Disopyramide—Muscular weakness—Doxorubicin—stomach cancer	0.00113	0.00183	CcSEcCtD
Disopyramide—Vision blurred—Capecitabine—stomach cancer	0.00113	0.00183	CcSEcCtD
Disopyramide—Dysuria—Epirubicin—stomach cancer	0.00112	0.00181	CcSEcCtD
Disopyramide—Neutropenia—Epirubicin—stomach cancer	0.00112	0.00181	CcSEcCtD
Disopyramide—Abdominal distension—Doxorubicin—stomach cancer	0.00111	0.00181	CcSEcCtD
Disopyramide—Ill-defined disorder—Capecitabine—stomach cancer	0.00111	0.0018	CcSEcCtD
Disopyramide—Urticaria—Fluorouracil—stomach cancer	0.00111	0.0018	CcSEcCtD
Disopyramide—Syncope—Docetaxel—stomach cancer	0.00111	0.0018	CcSEcCtD
Disopyramide—Pollakiuria—Epirubicin—stomach cancer	0.00111	0.00179	CcSEcCtD
Disopyramide—Body temperature increased—Fluorouracil—stomach cancer	0.0011	0.00179	CcSEcCtD
Disopyramide—Weight increased—Epirubicin—stomach cancer	0.00109	0.00176	CcSEcCtD
Disopyramide—Loss of consciousness—Docetaxel—stomach cancer	0.00109	0.00176	CcSEcCtD
Disopyramide—Malaise—Capecitabine—stomach cancer	0.00108	0.00175	CcSEcCtD
Disopyramide—Vertigo—Capecitabine—stomach cancer	0.00107	0.00174	CcSEcCtD
Disopyramide—Syncope—Capecitabine—stomach cancer	0.00107	0.00174	CcSEcCtD
Disopyramide—Drowsiness—Epirubicin—stomach cancer	0.00107	0.00173	CcSEcCtD
Disopyramide—Agranulocytosis—Methotrexate—stomach cancer	0.00106	0.00172	CcSEcCtD
Disopyramide—Chest pain—Docetaxel—stomach cancer	0.00105	0.0017	CcSEcCtD
Disopyramide—Loss of consciousness—Capecitabine—stomach cancer	0.00105	0.0017	CcSEcCtD
Disopyramide—Asthenia—Irinotecan—stomach cancer	0.00105	0.0017	CcSEcCtD
Disopyramide—Dysuria—Doxorubicin—stomach cancer	0.00103	0.00168	CcSEcCtD
Disopyramide—Neutropenia—Doxorubicin—stomach cancer	0.00103	0.00168	CcSEcCtD
Disopyramide—Dry mouth—Docetaxel—stomach cancer	0.00103	0.00167	CcSEcCtD
Disopyramide—Hepatitis—Methotrexate—stomach cancer	0.00102	0.00166	CcSEcCtD
Disopyramide—Pollakiuria—Doxorubicin—stomach cancer	0.00102	0.00166	CcSEcCtD
Disopyramide—Chest pain—Capecitabine—stomach cancer	0.00102	0.00165	CcSEcCtD
Disopyramide—Confusional state—Docetaxel—stomach cancer	0.00102	0.00165	CcSEcCtD
Disopyramide—Oedema—Docetaxel—stomach cancer	0.00101	0.00163	CcSEcCtD
Disopyramide—Weight increased—Doxorubicin—stomach cancer	0.00101	0.00163	CcSEcCtD
Disopyramide—Discomfort—Capecitabine—stomach cancer	0.00101	0.00163	CcSEcCtD
Disopyramide—Diarrhoea—Irinotecan—stomach cancer	0.000998	0.00162	CcSEcCtD
Disopyramide—Dry mouth—Capecitabine—stomach cancer	0.000996	0.00161	CcSEcCtD
Disopyramide—Agranulocytosis—Epirubicin—stomach cancer	0.000995	0.00161	CcSEcCtD
Disopyramide—Shock—Docetaxel—stomach cancer	0.000992	0.00161	CcSEcCtD
Disopyramide—Pruritus—Fluorouracil—stomach cancer	0.000989	0.0016	CcSEcCtD
Disopyramide—Thrombocytopenia—Docetaxel—stomach cancer	0.000987	0.0016	CcSEcCtD
Disopyramide—Drowsiness—Doxorubicin—stomach cancer	0.000987	0.0016	CcSEcCtD
Disopyramide—Confusional state—Capecitabine—stomach cancer	0.000985	0.0016	CcSEcCtD
Disopyramide—Skin disorder—Docetaxel—stomach cancer	0.00098	0.00159	CcSEcCtD
Disopyramide—Oedema—Capecitabine—stomach cancer	0.000976	0.00158	CcSEcCtD
Disopyramide—Bradycardia—Epirubicin—stomach cancer	0.000975	0.00158	CcSEcCtD
Disopyramide—Dizziness—Irinotecan—stomach cancer	0.000965	0.00156	CcSEcCtD
Disopyramide—Anorexia—Docetaxel—stomach cancer	0.000961	0.00156	CcSEcCtD
Disopyramide—Shock—Capecitabine—stomach cancer	0.000961	0.00156	CcSEcCtD
Disopyramide—Hepatitis—Epirubicin—stomach cancer	0.000957	0.00155	CcSEcCtD
Disopyramide—Diarrhoea—Fluorouracil—stomach cancer	0.000956	0.00155	CcSEcCtD
Disopyramide—Thrombocytopenia—Capecitabine—stomach cancer	0.000956	0.00155	CcSEcCtD
Disopyramide—Hypoaesthesia—Epirubicin—stomach cancer	0.000953	0.00154	CcSEcCtD
Disopyramide—Skin disorder—Capecitabine—stomach cancer	0.000948	0.00154	CcSEcCtD
Disopyramide—Hyperhidrosis—Capecitabine—stomach cancer	0.000944	0.00153	CcSEcCtD
Disopyramide—Hypotension—Docetaxel—stomach cancer	0.000942	0.00153	CcSEcCtD
Disopyramide—Anorexia—Capecitabine—stomach cancer	0.000931	0.00151	CcSEcCtD
Disopyramide—Vomiting—Irinotecan—stomach cancer	0.000928	0.0015	CcSEcCtD
Disopyramide—Dizziness—Fluorouracil—stomach cancer	0.000924	0.0015	CcSEcCtD
Disopyramide—Agranulocytosis—Doxorubicin—stomach cancer	0.000921	0.00149	CcSEcCtD
Disopyramide—Rash—Irinotecan—stomach cancer	0.00092	0.00149	CcSEcCtD
Disopyramide—Dermatitis—Irinotecan—stomach cancer	0.000919	0.00149	CcSEcCtD
Disopyramide—Headache—Irinotecan—stomach cancer	0.000914	0.00148	CcSEcCtD
Disopyramide—Hypotension—Capecitabine—stomach cancer	0.000912	0.00148	CcSEcCtD
Disopyramide—Insomnia—Docetaxel—stomach cancer	0.000912	0.00148	CcSEcCtD
Disopyramide—Paraesthesia—Docetaxel—stomach cancer	0.000906	0.00147	CcSEcCtD
Disopyramide—Bradycardia—Doxorubicin—stomach cancer	0.000902	0.00146	CcSEcCtD
Disopyramide—Dyspnoea—Docetaxel—stomach cancer	0.000899	0.00146	CcSEcCtD
Disopyramide—Somnolence—Docetaxel—stomach cancer	0.000897	0.00145	CcSEcCtD
Disopyramide—Vomiting—Fluorouracil—stomach cancer	0.000888	0.00144	CcSEcCtD
Disopyramide—Dyspepsia—Docetaxel—stomach cancer	0.000888	0.00144	CcSEcCtD
Disopyramide—Hepatitis—Doxorubicin—stomach cancer	0.000886	0.00144	CcSEcCtD
Disopyramide—Insomnia—Capecitabine—stomach cancer	0.000883	0.00143	CcSEcCtD
Disopyramide—Hypoaesthesia—Doxorubicin—stomach cancer	0.000881	0.00143	CcSEcCtD
Disopyramide—Rash—Fluorouracil—stomach cancer	0.000881	0.00143	CcSEcCtD
Disopyramide—Dermatitis—Fluorouracil—stomach cancer	0.00088	0.00143	CcSEcCtD
Disopyramide—Paraesthesia—Capecitabine—stomach cancer	0.000877	0.00142	CcSEcCtD
Disopyramide—Decreased appetite—Docetaxel—stomach cancer	0.000877	0.00142	CcSEcCtD
Disopyramide—Headache—Fluorouracil—stomach cancer	0.000875	0.00142	CcSEcCtD
Disopyramide—Dysgeusia—Methotrexate—stomach cancer	0.000872	0.00141	CcSEcCtD
Disopyramide—Dyspnoea—Capecitabine—stomach cancer	0.000871	0.00141	CcSEcCtD
Disopyramide—Fatigue—Docetaxel—stomach cancer	0.000869	0.00141	CcSEcCtD
Disopyramide—Nausea—Irinotecan—stomach cancer	0.000867	0.0014	CcSEcCtD
Disopyramide—Constipation—Docetaxel—stomach cancer	0.000862	0.0014	CcSEcCtD
Disopyramide—Pain—Docetaxel—stomach cancer	0.000862	0.0014	CcSEcCtD
Disopyramide—Dyspepsia—Capecitabine—stomach cancer	0.000859	0.00139	CcSEcCtD
Disopyramide—Arrhythmia—Epirubicin—stomach cancer	0.000855	0.00139	CcSEcCtD
Disopyramide—Decreased appetite—Capecitabine—stomach cancer	0.000849	0.00138	CcSEcCtD
Disopyramide—Fatigue—Capecitabine—stomach cancer	0.000842	0.00136	CcSEcCtD
Disopyramide—Vision blurred—Methotrexate—stomach cancer	0.000839	0.00136	CcSEcCtD
Disopyramide—Pain—Capecitabine—stomach cancer	0.000835	0.00135	CcSEcCtD
Disopyramide—Constipation—Capecitabine—stomach cancer	0.000835	0.00135	CcSEcCtD
Disopyramide—Feeling abnormal—Docetaxel—stomach cancer	0.000831	0.00135	CcSEcCtD
Disopyramide—Nausea—Fluorouracil—stomach cancer	0.00083	0.00134	CcSEcCtD
Disopyramide—Ill-defined disorder—Methotrexate—stomach cancer	0.000826	0.00134	CcSEcCtD
Disopyramide—Flatulence—Epirubicin—stomach cancer	0.000821	0.00133	CcSEcCtD
Disopyramide—Tension—Epirubicin—stomach cancer	0.000818	0.00133	CcSEcCtD
Disopyramide—Dysgeusia—Epirubicin—stomach cancer	0.000816	0.00132	CcSEcCtD
Disopyramide—Nervousness—Epirubicin—stomach cancer	0.00081	0.00131	CcSEcCtD
Disopyramide—Feeling abnormal—Capecitabine—stomach cancer	0.000805	0.0013	CcSEcCtD
Disopyramide—Malaise—Methotrexate—stomach cancer	0.000803	0.0013	CcSEcCtD
Disopyramide—Vertigo—Methotrexate—stomach cancer	0.0008	0.0013	CcSEcCtD
Disopyramide—Body temperature increased—Docetaxel—stomach cancer	0.000797	0.00129	CcSEcCtD
Disopyramide—Arrhythmia—Doxorubicin—stomach cancer	0.000791	0.00128	CcSEcCtD
Disopyramide—Vision blurred—Epirubicin—stomach cancer	0.000785	0.00127	CcSEcCtD
Disopyramide—Urticaria—Capecitabine—stomach cancer	0.000776	0.00126	CcSEcCtD
Disopyramide—Ill-defined disorder—Epirubicin—stomach cancer	0.000773	0.00125	CcSEcCtD
Disopyramide—Body temperature increased—Capecitabine—stomach cancer	0.000772	0.00125	CcSEcCtD
Disopyramide—Flatulence—Doxorubicin—stomach cancer	0.00076	0.00123	CcSEcCtD
Disopyramide—Chest pain—Methotrexate—stomach cancer	0.000758	0.00123	CcSEcCtD
Disopyramide—Tension—Doxorubicin—stomach cancer	0.000757	0.00123	CcSEcCtD
Disopyramide—Dysgeusia—Doxorubicin—stomach cancer	0.000755	0.00122	CcSEcCtD
Disopyramide—Malaise—Epirubicin—stomach cancer	0.000752	0.00122	CcSEcCtD
Disopyramide—Discomfort—Methotrexate—stomach cancer	0.000749	0.00121	CcSEcCtD
Disopyramide—Nervousness—Doxorubicin—stomach cancer	0.000749	0.00121	CcSEcCtD
Disopyramide—Vertigo—Epirubicin—stomach cancer	0.000749	0.00121	CcSEcCtD
Disopyramide—Syncope—Epirubicin—stomach cancer	0.000747	0.00121	CcSEcCtD
Disopyramide—Confusional state—Methotrexate—stomach cancer	0.000733	0.00119	CcSEcCtD
Disopyramide—Loss of consciousness—Epirubicin—stomach cancer	0.000733	0.00119	CcSEcCtD
Disopyramide—Vision blurred—Doxorubicin—stomach cancer	0.000727	0.00118	CcSEcCtD
Disopyramide—Asthenia—Docetaxel—stomach cancer	0.000724	0.00117	CcSEcCtD
Disopyramide—Ill-defined disorder—Doxorubicin—stomach cancer	0.000716	0.00116	CcSEcCtD
Disopyramide—Pruritus—Docetaxel—stomach cancer	0.000714	0.00116	CcSEcCtD
Disopyramide—Thrombocytopenia—Methotrexate—stomach cancer	0.000712	0.00115	CcSEcCtD
Disopyramide—Chest pain—Epirubicin—stomach cancer	0.00071	0.00115	CcSEcCtD
Disopyramide—Skin disorder—Methotrexate—stomach cancer	0.000706	0.00114	CcSEcCtD
Disopyramide—Hyperhidrosis—Methotrexate—stomach cancer	0.000703	0.00114	CcSEcCtD
Disopyramide—Discomfort—Epirubicin—stomach cancer	0.000701	0.00114	CcSEcCtD
Disopyramide—Asthenia—Capecitabine—stomach cancer	0.000701	0.00114	CcSEcCtD
Disopyramide—Malaise—Doxorubicin—stomach cancer	0.000695	0.00113	CcSEcCtD
Disopyramide—Dry mouth—Epirubicin—stomach cancer	0.000694	0.00112	CcSEcCtD
Disopyramide—Vertigo—Doxorubicin—stomach cancer	0.000693	0.00112	CcSEcCtD
Disopyramide—Anorexia—Methotrexate—stomach cancer	0.000693	0.00112	CcSEcCtD
Disopyramide—Syncope—Doxorubicin—stomach cancer	0.000692	0.00112	CcSEcCtD
Disopyramide—Pruritus—Capecitabine—stomach cancer	0.000691	0.00112	CcSEcCtD
Disopyramide—Diarrhoea—Docetaxel—stomach cancer	0.00069	0.00112	CcSEcCtD
Disopyramide—Confusional state—Epirubicin—stomach cancer	0.000686	0.00111	CcSEcCtD
Disopyramide—Oedema—Epirubicin—stomach cancer	0.00068	0.0011	CcSEcCtD
Disopyramide—Hypotension—Methotrexate—stomach cancer	0.000679	0.0011	CcSEcCtD
Disopyramide—Loss of consciousness—Doxorubicin—stomach cancer	0.000678	0.0011	CcSEcCtD
Disopyramide—Shock—Epirubicin—stomach cancer	0.000669	0.00108	CcSEcCtD
Disopyramide—Diarrhoea—Capecitabine—stomach cancer	0.000668	0.00108	CcSEcCtD
Disopyramide—Dizziness—Docetaxel—stomach cancer	0.000667	0.00108	CcSEcCtD
Disopyramide—Thrombocytopenia—Epirubicin—stomach cancer	0.000666	0.00108	CcSEcCtD
Disopyramide—Skin disorder—Epirubicin—stomach cancer	0.000661	0.00107	CcSEcCtD
Disopyramide—Hyperhidrosis—Epirubicin—stomach cancer	0.000658	0.00107	CcSEcCtD
Disopyramide—Insomnia—Methotrexate—stomach cancer	0.000657	0.00107	CcSEcCtD
Disopyramide—Chest pain—Doxorubicin—stomach cancer	0.000657	0.00106	CcSEcCtD
Disopyramide—Paraesthesia—Methotrexate—stomach cancer	0.000653	0.00106	CcSEcCtD
Disopyramide—Discomfort—Doxorubicin—stomach cancer	0.000649	0.00105	CcSEcCtD
Disopyramide—Anorexia—Epirubicin—stomach cancer	0.000648	0.00105	CcSEcCtD
Disopyramide—Dyspnoea—Methotrexate—stomach cancer	0.000648	0.00105	CcSEcCtD
Disopyramide—Somnolence—Methotrexate—stomach cancer	0.000646	0.00105	CcSEcCtD
Disopyramide—Dizziness—Capecitabine—stomach cancer	0.000646	0.00105	CcSEcCtD
Disopyramide—Dry mouth—Doxorubicin—stomach cancer	0.000642	0.00104	CcSEcCtD
Disopyramide—Vomiting—Docetaxel—stomach cancer	0.000641	0.00104	CcSEcCtD
Disopyramide—Dyspepsia—Methotrexate—stomach cancer	0.00064	0.00104	CcSEcCtD
Disopyramide—Rash—Docetaxel—stomach cancer	0.000636	0.00103	CcSEcCtD
Disopyramide—Hypotension—Epirubicin—stomach cancer	0.000636	0.00103	CcSEcCtD
Disopyramide—Dermatitis—Docetaxel—stomach cancer	0.000635	0.00103	CcSEcCtD
Disopyramide—Confusional state—Doxorubicin—stomach cancer	0.000635	0.00103	CcSEcCtD
Disopyramide—Decreased appetite—Methotrexate—stomach cancer	0.000632	0.00102	CcSEcCtD
Disopyramide—Headache—Docetaxel—stomach cancer	0.000632	0.00102	CcSEcCtD
Disopyramide—Oedema—Doxorubicin—stomach cancer	0.000629	0.00102	CcSEcCtD
Disopyramide—Fatigue—Methotrexate—stomach cancer	0.000627	0.00102	CcSEcCtD
Disopyramide—Pain—Methotrexate—stomach cancer	0.000622	0.00101	CcSEcCtD
Disopyramide—Vomiting—Capecitabine—stomach cancer	0.000621	0.00101	CcSEcCtD
Disopyramide—Shock—Doxorubicin—stomach cancer	0.000619	0.001	CcSEcCtD
Disopyramide—Thrombocytopenia—Doxorubicin—stomach cancer	0.000616	0.000999	CcSEcCtD
Disopyramide—Rash—Capecitabine—stomach cancer	0.000616	0.000998	CcSEcCtD
Disopyramide—Insomnia—Epirubicin—stomach cancer	0.000615	0.000997	CcSEcCtD
Disopyramide—Dermatitis—Capecitabine—stomach cancer	0.000615	0.000997	CcSEcCtD
Disopyramide—Headache—Capecitabine—stomach cancer	0.000612	0.000991	CcSEcCtD
Disopyramide—Skin disorder—Doxorubicin—stomach cancer	0.000611	0.000991	CcSEcCtD
Disopyramide—Paraesthesia—Epirubicin—stomach cancer	0.000611	0.00099	CcSEcCtD
Disopyramide—Hyperhidrosis—Doxorubicin—stomach cancer	0.000608	0.000986	CcSEcCtD
Disopyramide—Dyspnoea—Epirubicin—stomach cancer	0.000606	0.000983	CcSEcCtD
Disopyramide—Somnolence—Epirubicin—stomach cancer	0.000605	0.00098	CcSEcCtD
Disopyramide—Anorexia—Doxorubicin—stomach cancer	0.0006	0.000972	CcSEcCtD
Disopyramide—Nausea—Docetaxel—stomach cancer	0.000599	0.000971	CcSEcCtD
Disopyramide—Feeling abnormal—Methotrexate—stomach cancer	0.000599	0.000971	CcSEcCtD
Disopyramide—Dyspepsia—Epirubicin—stomach cancer	0.000599	0.00097	CcSEcCtD
Disopyramide—Decreased appetite—Epirubicin—stomach cancer	0.000591	0.000958	CcSEcCtD
Disopyramide—Hypotension—Doxorubicin—stomach cancer	0.000588	0.000953	CcSEcCtD
Disopyramide—Fatigue—Epirubicin—stomach cancer	0.000586	0.00095	CcSEcCtD
Disopyramide—Pain—Epirubicin—stomach cancer	0.000582	0.000943	CcSEcCtD
Disopyramide—Constipation—Epirubicin—stomach cancer	0.000582	0.000943	CcSEcCtD
Disopyramide—Nausea—Capecitabine—stomach cancer	0.00058	0.00094	CcSEcCtD
Disopyramide—Urticaria—Methotrexate—stomach cancer	0.000577	0.000936	CcSEcCtD
Disopyramide—Body temperature increased—Methotrexate—stomach cancer	0.000575	0.000931	CcSEcCtD
Disopyramide—Insomnia—Doxorubicin—stomach cancer	0.000569	0.000922	CcSEcCtD
Disopyramide—Paraesthesia—Doxorubicin—stomach cancer	0.000565	0.000916	CcSEcCtD
Disopyramide—Dyspnoea—Doxorubicin—stomach cancer	0.000561	0.000909	CcSEcCtD
Disopyramide—Feeling abnormal—Epirubicin—stomach cancer	0.000561	0.000908	CcSEcCtD
Disopyramide—Somnolence—Doxorubicin—stomach cancer	0.00056	0.000907	CcSEcCtD
Disopyramide—Dyspepsia—Doxorubicin—stomach cancer	0.000554	0.000898	CcSEcCtD
Disopyramide—Decreased appetite—Doxorubicin—stomach cancer	0.000547	0.000887	CcSEcCtD
Disopyramide—Fatigue—Doxorubicin—stomach cancer	0.000543	0.000879	CcSEcCtD
Disopyramide—Urticaria—Epirubicin—stomach cancer	0.00054	0.000876	CcSEcCtD
Disopyramide—Pain—Doxorubicin—stomach cancer	0.000538	0.000872	CcSEcCtD
Disopyramide—Constipation—Doxorubicin—stomach cancer	0.000538	0.000872	CcSEcCtD
Disopyramide—Body temperature increased—Epirubicin—stomach cancer	0.000538	0.000871	CcSEcCtD
Disopyramide—Asthenia—Methotrexate—stomach cancer	0.000522	0.000845	CcSEcCtD
Disopyramide—Feeling abnormal—Doxorubicin—stomach cancer	0.000519	0.00084	CcSEcCtD
Disopyramide—Pruritus—Methotrexate—stomach cancer	0.000514	0.000833	CcSEcCtD
Disopyramide—Urticaria—Doxorubicin—stomach cancer	0.0005	0.00081	CcSEcCtD
Disopyramide—Body temperature increased—Doxorubicin—stomach cancer	0.000498	0.000806	CcSEcCtD
Disopyramide—Diarrhoea—Methotrexate—stomach cancer	0.000497	0.000806	CcSEcCtD
Disopyramide—Asthenia—Epirubicin—stomach cancer	0.000488	0.000791	CcSEcCtD
Disopyramide—Pruritus—Epirubicin—stomach cancer	0.000481	0.00078	CcSEcCtD
Disopyramide—Dizziness—Methotrexate—stomach cancer	0.000481	0.000779	CcSEcCtD
Disopyramide—Diarrhoea—Epirubicin—stomach cancer	0.000465	0.000754	CcSEcCtD
Disopyramide—Vomiting—Methotrexate—stomach cancer	0.000462	0.000749	CcSEcCtD
Disopyramide—Rash—Methotrexate—stomach cancer	0.000458	0.000743	CcSEcCtD
Disopyramide—Dermatitis—Methotrexate—stomach cancer	0.000458	0.000742	CcSEcCtD
Disopyramide—Headache—Methotrexate—stomach cancer	0.000455	0.000738	CcSEcCtD
Disopyramide—Asthenia—Doxorubicin—stomach cancer	0.000452	0.000732	CcSEcCtD
Disopyramide—Dizziness—Epirubicin—stomach cancer	0.00045	0.000729	CcSEcCtD
Disopyramide—Pruritus—Doxorubicin—stomach cancer	0.000445	0.000722	CcSEcCtD
Disopyramide—Vomiting—Epirubicin—stomach cancer	0.000432	0.000701	CcSEcCtD
Disopyramide—Nausea—Methotrexate—stomach cancer	0.000432	0.0007	CcSEcCtD
Disopyramide—Diarrhoea—Doxorubicin—stomach cancer	0.000431	0.000698	CcSEcCtD
Disopyramide—Rash—Epirubicin—stomach cancer	0.000429	0.000695	CcSEcCtD
Disopyramide—Dermatitis—Epirubicin—stomach cancer	0.000428	0.000694	CcSEcCtD
Disopyramide—Headache—Epirubicin—stomach cancer	0.000426	0.000691	CcSEcCtD
Disopyramide—Dizziness—Doxorubicin—stomach cancer	0.000416	0.000674	CcSEcCtD
Disopyramide—Nausea—Epirubicin—stomach cancer	0.000404	0.000655	CcSEcCtD
Disopyramide—Vomiting—Doxorubicin—stomach cancer	0.0004	0.000648	CcSEcCtD
Disopyramide—Rash—Doxorubicin—stomach cancer	0.000397	0.000643	CcSEcCtD
Disopyramide—Dermatitis—Doxorubicin—stomach cancer	0.000396	0.000642	CcSEcCtD
Disopyramide—Headache—Doxorubicin—stomach cancer	0.000394	0.000639	CcSEcCtD
Disopyramide—Nausea—Doxorubicin—stomach cancer	0.000374	0.000606	CcSEcCtD
Disopyramide—CHRM2—Signaling Pathways—BMP2—stomach cancer	5.16e-05	0.000261	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—F2R—stomach cancer	5.16e-05	0.000261	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKR1C3—stomach cancer	5.14e-05	0.00026	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTP1—stomach cancer	5.13e-05	0.000259	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKR1C3—stomach cancer	5.12e-05	0.000259	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR1A—stomach cancer	5.08e-05	0.000257	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKR1C3—stomach cancer	5.07e-05	0.000256	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR1A—stomach cancer	5.07e-05	0.000256	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—HMOX1—stomach cancer	5.06e-05	0.000256	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR1A—stomach cancer	5.02e-05	0.000254	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NDUFA2—stomach cancer	4.98e-05	0.000252	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—FBP1—stomach cancer	4.98e-05	0.000252	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CKB—stomach cancer	4.98e-05	0.000252	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CA1—stomach cancer	4.98e-05	0.000252	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PRKCB—stomach cancer	4.92e-05	0.000249	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ANXA1—stomach cancer	4.91e-05	0.000248	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PRKCB—stomach cancer	4.91e-05	0.000248	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ANXA1—stomach cancer	4.89e-05	0.000247	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPP2R1A—stomach cancer	4.87e-05	0.000246	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PRKCB—stomach cancer	4.86e-05	0.000246	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ANXA1—stomach cancer	4.85e-05	0.000245	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTP1—stomach cancer	4.78e-05	0.000242	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—TYMS—stomach cancer	4.77e-05	0.000241	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRB1—stomach cancer	4.76e-05	0.00024	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRB1—stomach cancer	4.74e-05	0.00024	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—HMOX1—stomach cancer	4.71e-05	0.000238	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTM1—stomach cancer	4.71e-05	0.000238	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRB1—stomach cancer	4.69e-05	0.000237	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLIN2—stomach cancer	4.69e-05	0.000237	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CA2—stomach cancer	4.56e-05	0.00023	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RPS6—stomach cancer	4.54e-05	0.00023	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RPS6—stomach cancer	4.53e-05	0.000229	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPP2R1A—stomach cancer	4.5e-05	0.000228	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RPS6—stomach cancer	4.48e-05	0.000227	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PRKCB—stomach cancer	4.47e-05	0.000226	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PRKCB—stomach cancer	4.46e-05	0.000225	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6ST—stomach cancer	4.45e-05	0.000225	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—TYMS—stomach cancer	4.44e-05	0.000225	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NT5E—stomach cancer	4.44e-05	0.000225	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PGAM1—stomach cancer	4.44e-05	0.000225	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6ST—stomach cancer	4.44e-05	0.000224	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ERCC2—stomach cancer	4.43e-05	0.000224	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTP1—stomach cancer	4.42e-05	0.000223	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PRKCB—stomach cancer	4.41e-05	0.000223	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6ST—stomach cancer	4.4e-05	0.000222	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTM1—stomach cancer	4.39e-05	0.000222	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—HMOX1—stomach cancer	4.35e-05	0.00022	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDH7A1—stomach cancer	4.24e-05	0.000214	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLCE1—stomach cancer	4.24e-05	0.000214	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HBEGF—stomach cancer	4.18e-05	0.000211	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—MTHFR—stomach cancer	4.16e-05	0.00021	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HBEGF—stomach cancer	4.16e-05	0.00021	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ERCC2—stomach cancer	4.13e-05	0.000209	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HBEGF—stomach cancer	4.12e-05	0.000208	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TYMS—stomach cancer	4.1e-05	0.000207	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—UMPS—stomach cancer	4.06e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTM1—stomach cancer	4.06e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6R—stomach cancer	3.97e-05	0.000201	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6R—stomach cancer	3.96e-05	0.0002	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	3.95e-05	0.0002	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—RHOA—stomach cancer	3.94e-05	0.000199	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6R—stomach cancer	3.92e-05	0.000198	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	3.9e-05	0.000197	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—MTHFR—stomach cancer	3.88e-05	0.000196	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRB2—stomach cancer	3.85e-05	0.000195	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CAV1—stomach cancer	3.84e-05	0.000194	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRB2—stomach cancer	3.84e-05	0.000194	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—APOA1—stomach cancer	3.83e-05	0.000194	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ERCC2—stomach cancer	3.81e-05	0.000193	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRB2—stomach cancer	3.8e-05	0.000192	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ECHS1—stomach cancer	3.78e-05	0.000191	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PDHA1—stomach cancer	3.78e-05	0.000191	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	3.78e-05	0.000191	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	3.76e-05	0.00019	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	3.73e-05	0.000188	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—RHOA—stomach cancer	3.59e-05	0.000181	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—MTHFR—stomach cancer	3.59e-05	0.000181	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CAV1—stomach cancer	3.58e-05	0.000181	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—RHOA—stomach cancer	3.58e-05	0.000181	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—APOA1—stomach cancer	3.57e-05	0.000181	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TYMP—stomach cancer	3.55e-05	0.000179	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—FADS1—stomach cancer	3.55e-05	0.000179	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—RHOA—stomach cancer	3.54e-05	0.000179	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SMAD4—stomach cancer	3.51e-05	0.000177	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SMAD4—stomach cancer	3.49e-05	0.000177	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	3.47e-05	0.000175	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SMAD4—stomach cancer	3.46e-05	0.000175	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	3.46e-05	0.000175	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	3.42e-05	0.000173	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARG—stomach cancer	3.38e-05	0.000171	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FYN—stomach cancer	3.33e-05	0.000168	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SREBF2—stomach cancer	3.33e-05	0.000168	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FYN—stomach cancer	3.32e-05	0.000168	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CAV1—stomach cancer	3.31e-05	0.000167	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOA1—stomach cancer	3.3e-05	0.000167	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FYN—stomach cancer	3.29e-05	0.000166	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—RORA—stomach cancer	3.29e-05	0.000166	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	3.15e-05	0.000159	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARG—stomach cancer	3.15e-05	0.000159	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	3.14e-05	0.000159	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FGFR2—stomach cancer	3.12e-05	0.000158	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FGFR2—stomach cancer	3.11e-05	0.000157	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	3.11e-05	0.000157	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FGFR2—stomach cancer	3.08e-05	0.000156	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDOB—stomach cancer	3.08e-05	0.000156	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALB—stomach cancer	3.04e-05	0.000153	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARG—stomach cancer	2.91e-05	0.000147	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NOS3—stomach cancer	2.9e-05	0.000147	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALOX5—stomach cancer	2.86e-05	0.000145	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IRS2—stomach cancer	2.86e-05	0.000145	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IRS2—stomach cancer	2.85e-05	0.000144	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALB—stomach cancer	2.83e-05	0.000143	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IRS2—stomach cancer	2.82e-05	0.000143	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—DPYD—stomach cancer	2.82e-05	0.000142	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CAV1—stomach cancer	2.77e-05	0.00014	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOA1—stomach cancer	2.77e-05	0.00014	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CAV1—stomach cancer	2.77e-05	0.00014	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOA1—stomach cancer	2.76e-05	0.000139	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CAV1—stomach cancer	2.74e-05	0.000138	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOA1—stomach cancer	2.73e-05	0.000138	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NOS3—stomach cancer	2.71e-05	0.000137	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—stomach cancer	2.66e-05	0.000134	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRKCB—stomach cancer	2.64e-05	0.000133	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRKCB—stomach cancer	2.63e-05	0.000133	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6ST—stomach cancer	2.63e-05	0.000133	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6ST—stomach cancer	2.62e-05	0.000133	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALB—stomach cancer	2.61e-05	0.000132	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRKCB—stomach cancer	2.61e-05	0.000132	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6ST—stomach cancer	2.6e-05	0.000131	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APC—stomach cancer	2.53e-05	0.000128	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APC—stomach cancer	2.52e-05	0.000127	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NOS3—stomach cancer	2.5e-05	0.000126	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APC—stomach cancer	2.49e-05	0.000126	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTT1—stomach cancer	2.49e-05	0.000126	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—stomach cancer	2.48e-05	0.000125	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.46e-05	0.000124	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	2.42e-05	0.000122	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	2.41e-05	0.000122	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.39e-05	0.000121	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	2.39e-05	0.000121	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6R—stomach cancer	2.35e-05	0.000119	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6R—stomach cancer	2.34e-05	0.000118	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ENO1—stomach cancer	2.33e-05	0.000118	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6R—stomach cancer	2.32e-05	0.000117	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	2.3e-05	0.000116	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—EGFR—stomach cancer	2.3e-05	0.000116	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	2.3e-05	0.000116	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—EGFR—stomach cancer	2.3e-05	0.000116	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—stomach cancer	2.29e-05	0.000116	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	2.27e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—EGFR—stomach cancer	2.27e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	2.2e-05	0.000111	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	2.2e-05	0.000111	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	2.19e-05	0.000111	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	2.19e-05	0.000111	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—KRAS—stomach cancer	2.18e-05	0.00011	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	2.17e-05	0.00011	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	2.17e-05	0.00011	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—KRAS—stomach cancer	2.17e-05	0.00011	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—KRAS—stomach cancer	2.15e-05	0.000109	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RHOA—stomach cancer	2.12e-05	0.000107	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RHOA—stomach cancer	2.11e-05	0.000107	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOS3—stomach cancer	2.1e-05	0.000106	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RHOA—stomach cancer	2.09e-05	0.000106	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOS3—stomach cancer	2.09e-05	0.000106	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOS3—stomach cancer	2.07e-05	0.000105	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CD44—stomach cancer	2.07e-05	0.000105	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	2e-05	0.000101	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	1.99e-05	0.000101	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	1.97e-05	9.97e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ERBB2—stomach cancer	1.96e-05	9.92e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ERBB2—stomach cancer	1.96e-05	9.89e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ERBB2—stomach cancer	1.94e-05	9.79e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL8—stomach cancer	1.86e-05	9.41e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL8—stomach cancer	1.85e-05	9.38e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HRAS—stomach cancer	1.85e-05	9.34e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HRAS—stomach cancer	1.84e-05	9.31e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL8—stomach cancer	1.84e-05	9.28e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HRAS—stomach cancer	1.83e-05	9.22e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	1.82e-05	9.19e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	1.81e-05	9.16e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	1.79e-05	9.07e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6—stomach cancer	1.77e-05	8.94e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6—stomach cancer	1.76e-05	8.92e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.76e-05	8.89e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6—stomach cancer	1.75e-05	8.83e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCND1—stomach cancer	1.73e-05	8.76e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—JUN—stomach cancer	1.73e-05	8.74e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCND1—stomach cancer	1.73e-05	8.73e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTP1—stomach cancer	1.73e-05	8.72e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—JUN—stomach cancer	1.72e-05	8.72e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCND1—stomach cancer	1.71e-05	8.65e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—JUN—stomach cancer	1.71e-05	8.63e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMOX1—stomach cancer	1.7e-05	8.6e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—stomach cancer	1.68e-05	8.51e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—stomach cancer	1.68e-05	8.48e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	1.68e-05	8.48e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	1.67e-05	8.45e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—stomach cancer	1.66e-05	8.4e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	1.66e-05	8.37e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK8—stomach cancer	1.64e-05	8.27e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CA—stomach cancer	1.63e-05	8.26e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK8—stomach cancer	1.63e-05	8.25e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK8—stomach cancer	1.62e-05	8.17e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TYMS—stomach cancer	1.6e-05	8.11e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTM1—stomach cancer	1.59e-05	8.02e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CA—stomach cancer	1.52e-05	7.7e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—stomach cancer	1.51e-05	7.64e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—stomach cancer	1.51e-05	7.61e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—STAT3—stomach cancer	1.5e-05	7.56e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—stomach cancer	1.49e-05	7.54e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—STAT3—stomach cancer	1.49e-05	7.54e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ERCC2—stomach cancer	1.49e-05	7.54e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—STAT3—stomach cancer	1.48e-05	7.47e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK3—stomach cancer	1.43e-05	7.23e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK3—stomach cancer	1.43e-05	7.2e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK3—stomach cancer	1.41e-05	7.13e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CA—stomach cancer	1.41e-05	7.11e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MTHFR—stomach cancer	1.4e-05	7.08e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MYC—stomach cancer	1.39e-05	7.03e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MYC—stomach cancer	1.39e-05	7.01e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MYC—stomach cancer	1.37e-05	6.94e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK1—stomach cancer	1.36e-05	6.88e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EGFR—stomach cancer	1.36e-05	6.87e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK1—stomach cancer	1.36e-05	6.85e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EGFR—stomach cancer	1.36e-05	6.85e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK1—stomach cancer	1.34e-05	6.79e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EGFR—stomach cancer	1.34e-05	6.79e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CAV1—stomach cancer	1.29e-05	6.54e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOA1—stomach cancer	1.29e-05	6.52e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KRAS—stomach cancer	1.28e-05	6.49e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KRAS—stomach cancer	1.28e-05	6.47e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KRAS—stomach cancer	1.27e-05	6.41e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.18e-05	5.97e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	1.18e-05	5.95e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	1.17e-05	5.89e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—stomach cancer	1.14e-05	5.77e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—stomach cancer	1.14e-05	5.75e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARG—stomach cancer	1.14e-05	5.75e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—stomach cancer	1.13e-05	5.7e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.09e-05	5.52e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HRAS—stomach cancer	1.09e-05	5.5e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HRAS—stomach cancer	1.08e-05	5.45e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6—stomach cancer	1.05e-05	5.28e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6—stomach cancer	1.04e-05	5.27e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6—stomach cancer	1.03e-05	5.22e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALB—stomach cancer	1.02e-05	5.17e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NOS3—stomach cancer	9.78e-06	4.94e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—stomach cancer	8.94e-06	4.52e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CA—stomach cancer	5.5e-06	2.78e-05	CbGpPWpGaD
